Collective Coordinates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) and ProMIS Neurosciences (NASDAQ:PMN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Institutional and Insider Ownership 33.9% of Akebia […]

ProMIS Neurosciences, Inc. (NASDAQ:PMN – Get Free Report)’s stock price shot up 1.5% during mid-day trading on Friday . The company traded as high as $1.98 and last traded at $1.98. 1,032 shares were traded during trading, a decline of 97% from the average session volume of 37,766 shares. The stock had previously closed at […]

ProMIS Neurosciences, Inc. (NASDAQ:PMN – Free Report) – Equities research analysts at Leede Jones Gab issued their FY2028 earnings per share (EPS) estimates for ProMIS Neurosciences in a research report issued to clients and investors on Wednesday, April 3rd. Leede Jones Gab analyst D. Loe forecasts that the company will post earnings per share of […]

ProMIS Neurosciences, Inc. (NASDAQ:PMN – Get Free Report) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 24,000 shares, a growth of 21.8% from the February 29th total of 19,700 shares. Based on an average trading volume of 46,700 shares, the days-to-cover ratio […]

NASDAQ: PMN Corporate Presentation Legal Disclaimers This slide deck may contain certain...